Skip to content

Source filing unavailable

Q1 2021 · —
Revenue—
Net Income-$27.00Mno prior Q1 2020 on fileno prior Q4 2020 on file
EPS Diluted-$64.41no prior Q1 2020 on fileno prior Q4 2020 on file
Operating Income-$3,793,000—
Operating Cash Flow-$2,370,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR